Does PALBOCICLIB Cause Speech disorder? 255 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 255 reports of Speech disorder have been filed in association with PALBOCICLIB (Ibrance). This represents 0.3% of all adverse event reports for PALBOCICLIB.
255
Reports of Speech disorder with PALBOCICLIB
0.3%
of all PALBOCICLIB reports
22
Deaths
54
Hospitalizations
How Dangerous Is Speech disorder From PALBOCICLIB?
Of the 255 reports, 22 (8.6%) resulted in death, 54 (21.2%) required hospitalization, and 5 (2.0%) were considered life-threatening.
Is Speech disorder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PALBOCICLIB. However, 255 reports have been filed with the FAERS database.
What Other Side Effects Does PALBOCICLIB Cause?
Fatigue (15,190)
White blood cell count decreased (11,273)
Neoplasm progression (10,885)
Death (8,410)
Nausea (8,189)
Neutropenia (6,423)
Alopecia (6,201)
Diarrhoea (5,635)
Asthenia (3,660)
Off label use (3,405)
What Other Drugs Cause Speech disorder?
CARBIDOPA\LEVODOPA (1,291)
PREGABALIN (827)
QUETIAPINE (762)
ADALIMUMAB (684)
FINGOLIMOD (583)
DIMETHYL (576)
OLANZAPINE (547)
PIMAVANSERIN (540)
NATALIZUMAB (528)
GABAPENTIN (515)
Which PALBOCICLIB Alternatives Have Lower Speech disorder Risk?
PALBOCICLIB vs PALIPERIDONE
PALBOCICLIB vs PALIVIZUMAB
PALBOCICLIB vs PALONOSETRON
PALBOCICLIB vs PAMIDRONATE
PALBOCICLIB vs PAMIDRONIC ACID